Reported Adverse Effects In the available case series and observational literature, the most commonly reported adverse effects include: Injection-site redness or mild induration in approximately 8 to 12% of users Transient nausea, most often associated with oral formulations or higher injectable doses Lightheadedness in a small number of patients shortly after injection (under 2% of reported cases) Vivid dreams or mild sleep changes, reported anecdotally by a subset of users with no clear mechanistic explanation No published human case reports as of July 2025 document serious organ toxicity, malignancy, or endocrine disruption attributable to BPC-157
In hippocampal neuron cultures, Dihexa promoted synapse formation at picomolar concentrations, providing cellular-level evidence for its cognitive mechanism
Additionally, lactic acid impaired T cell motility and cytolytic activity
Delivered directly to your bloodstream, an intravenous glutathione infusion bypasses your gastrointestinal system where this substance can be slowly digested and absorbed faster
Additionally, injections carry potential risks, such as infections, and require higher commitment on your end